High-Tech Gruenderfonds, Bayern Kapital and a strategic partner invest in seiratherm GmbH
The High-Tech Gruenderfonds, Bayern Kapital and a strategic partner invest in the development of innovative devices for the regulation of the body-core temperature.
Seiratherm is working on innovative products for the controlled regulation of the body-core temperature. The therapy is intended to cool-down the patient (“hypothermia”), maintain a specific target temperature and subsequently rewarm the patient automatically.
The systematic lowering of the body-core temperature reduces the metabolic rate resulting in reduced neurological damages. This is beneficial for a multitude of indications in conjunction with hypoxia or insufficient oxygen supply affiliated with stroke.
Seiratherm combines clinically effective methods with state-of the art technology; the device application is fast, easy and favorably priced in comparison to competitors.
The investment by High-Tech Gruenderfonds, Bayern Kapital and the partner will enable seiratherm to develop the first generation of devices towards CE-certification.
Rosi Keimerl of Bayern Kapital and Dr. Martin Pfister of High-Tech Gründerfonds emphasized: “the automation of a clinical effective method with a patented technology will result in a better and cost-effective treatment option for critically-ill patients. This represents a very promising market potential and has upside potential withfurther indications. The involvement of a strategic partner further emphasizes the potential of seiratherm.
About seiratherm GmbH
The seiratherm GmbH was founded in 2011, however the interdisciplinary team of physicians and engineers is working since 2008 on innovative concepts for the regulation of the body-core temperature. Through the combination of clinically proven methods and state-of the art technology, seiratherm is able to develop innovative devices specially designed for the actual clinical demand. The company is based in Herzogenaurach.
Dr. Matthias Roth
Tel: +49 (0) 89 5484 268 0
Fax: +49 (0) 89 5484 268 0
About Bayern Kapital/ Seedfonds Bayern
Seedfonds Bayern is existing since 2003, in 2010 the Clusterfonds Seed GmbH & Co. KG was founded with a volume of 24 Mio. Euro to continue this seed-investment activities. The fund managed by Bayern Kapital GmbH invests venture capital in young and innovative Bavarian technology-companies with high prospects that are transferring promising research results to business enterprises. Bayern Kapital GmbH is a public Bavarian venture capital company and was founded as part of the “Bavarian Future Initiative” at the end of 1995. Bayern Kapital and its funds invested about 171 Mio. Euro in more than 210 companies. Overall, Bayern Kapital now manages a fund volume of 200 Mio. Euro.
About High-Tech Gruenderfonds
High-Tech Gruenderfonds invests in young, high potential high-tech start-ups. The seed financing provided is designed to enable start-ups to take an idea through prototyping and to market launch. Typically, High-Tech Gruenderfonds invests EUR 500,000 in the seed stage, with the potential for up to a total of EUR 2 million per portfolio company in follow-on financing. Investors in this public/private partnership include the Federal Ministry of Economics and Technology, the KfW Banking Group, as well as twelve industrial groups of ALTANA, BASF, B. Braun, Robert Bosch, CEWE Color, Daimler, Deutsche Post DHL, Deutsche Telekom, Qiagen, RWE Innogy, Tengelmann and Carl Zeiss. High-Tech Gruenderfonds has about EUR 560.5 million under management in two funds (EUR 272 million EUR HTGF I, EUR 288.5 million HTGF II).
High-Tech Gründerfonds Management GmbH
Dr. Martin Pfister
Tel: +49 228 823001-00
Fax: +49 228 823000-50